S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
NASDAQ:DNAY

Telesis Bio (DNAY) Stock Forecast, Price & News

$1.04
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$1.00
$1.08
50-Day Range
$1.04
$1.57
52-Week Range
$1.08
$11.02
Volume
43,397 shs
Average Volume
54,063 shs
Market Capitalization
$30.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Telesis Bio MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
380.8% Upside
$5.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.85) to ($1.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

685th out of 972 stocks

Analytical Instruments Industry

18th out of 28 stocks


DNAY stock logo

About Telesis Bio (NASDAQ:DNAY) Stock

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

DNAY Price History

DNAY Stock News Headlines

Telesis Bio (NASDAQ:DNAY) Trading Down 4.3%
Telesis Bio Appoints William Kullback CFO
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Telesis Bio appoints William Kullback as CFO
Telesis Bio Appoints William J. Kullback Chief Financial Officer
Telesis Bio (TBIO) Receives a Rating Update from a Top Analyst
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Telesis Bio: Q2 Earnings Snapshot
Telesis Bio (NASDAQ: DNAY)
Telesis Bio Inc (TBIO)
Telesis Bio: Q4 Earnings Snapshot
Telesis Bio, Inc. (DNAY)
Telesis Bio, Inc. (DNAY) Q3 2022 Earnings Call Transcript
See More Headlines
Receive DNAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter.

DNAY Company Calendar

Last Earnings
11/08/2021
Today
10/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DNAY
Fax
N/A
Employees
212
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+380.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-38,960,000.00
Net Margins
-251.04%
Pretax Margin
-250.94%

Debt

Sales & Book Value

Annual Sales
$21.04 million
Book Value
$3.10 per share

Miscellaneous

Free Float
20,606,000
Market Cap
$30.70 million
Optionable
Not Optionable
Beta
1.36
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Todd R. Nelson MBA (Age 55)
    Ph.D., Pres, CEO & Director
    Comp: $876.78k
  • Mr. Daniel G. Gibson Ph.D. (Age 45)
    Chief Technology Officer
    Comp: $436.54k
  • Mr. Eric Esser (Age 52)
    Chief Operating Officer
  • Richard Lepke
    Director of Investor Relations
  • Mr. Robert H. Cutler (Age 54)
    Chief Legal Officer
  • Ms. Laura B. Puga M.B.A. (Age 42)
    VP of People & Culture
  • Mr. Decky Goodrich M.B.A.
    Sr. VP of Commercial Operations
  • Mr. Brent M. Hunter
    Exec. Officer
  • Mr. Laurence Warden
    Sr. VP of Engineering & Instrumentation













DNAY Stock - Frequently Asked Questions

Should I buy or sell Telesis Bio stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Telesis Bio in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DNAY shares.
View DNAY analyst ratings
or view top-rated stocks.

What is Telesis Bio's stock price forecast for 2023?

1 brokerages have issued 1-year price targets for Telesis Bio's stock. Their DNAY share price forecasts range from $5.00 to $5.00. On average, they anticipate the company's share price to reach $5.00 in the next year. This suggests a possible upside of 380.8% from the stock's current price.
View analysts price targets for DNAY
or view top-rated stocks among Wall Street analysts.

How have DNAY shares performed in 2023?

Telesis Bio's stock was trading at $1.20 at the start of the year. Since then, DNAY shares have decreased by 13.3% and is now trading at $1.04.
View the best growth stocks for 2023 here
.

How were Telesis Bio's earnings last quarter?

Telesis Bio, Inc. (NASDAQ:DNAY) issued its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of ($0.28) by $0.06. The company earned $2.79 million during the quarter, compared to analysts' expectations of $2.93 million. Telesis Bio had a negative net margin of 251.04% and a negative trailing twelve-month return on equity of 73.65%.

When did Telesis Bio IPO?

(DNAY) raised $100 million in an IPO on Friday, June 18th 2021. The company issued 6,700,000 shares at $14.00-$16.00 per share. Jefferies, Cowen and KeyBanc Capital Markets served as the underwriters for the IPO.

What is Telesis Bio's stock symbol?

Telesis Bio trades on the NASDAQ under the ticker symbol "DNAY."

How do I buy shares of Telesis Bio?

Shares of DNAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Telesis Bio's stock price today?

One share of DNAY stock can currently be purchased for approximately $1.04.

How much money does Telesis Bio make?

Telesis Bio (NASDAQ:DNAY) has a market capitalization of $30.70 million and generates $21.04 million in revenue each year. The company earns $-38,960,000.00 in net income (profit) each year or ($1.80) on an earnings per share basis.

How many employees does Telesis Bio have?

The company employs 212 workers across the globe.

How can I contact Telesis Bio?

The official website for the company is codexdna.com. The company can be reached via phone at 858-228-4115 or via email at ir@codexdna.com.

This page (NASDAQ:DNAY) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -